Aflibercept: Completed Phase II enrollment

Regeneron disclosed in its 4Q10 earnings that partner sanofi-aventis completed enrollment of about

Read the full 136 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE